ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00428922
Brief Title: Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients

First Submitted : January 29, 2007
First Submitted that Met QC Criteria : January 29, 2007
First Posted : January 30, 2007 (Estimate)

Results First Submitted : November 10, 2015
Results First Submitted that Met QC Criteria : January 14, 2016
Results First Posted : February 12, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : July 11, 2018
Last Update Posted : August 9, 2018